Bibliografía:

 

1-    Roca Goderich R. Temas de Medicina Interna. Tomo II. Ed. Revoluviomaria.2da Ed.1991

2-    Thompson Mw, Mc Innes RR, Willard HF, Genetica en Medicina.4ta Ed. Ed Nasson SA. Barcelena , 1996.

3-    Robbins SL. Patología Estructural y Funcional. 1ra Ed. Ed Interamericana Sa, México, 1975.

4-    CecilL: Tratado de Medicina Interna Cap: Estudio Clínico de las enfermedades del Higado; Cap : Tumores Hepáticos: mac Gras Hill Interamericana México DF; 1998 p 861-90.

5-    Harrinson G. Principios de Medicina Interna . 2da Ed. Cap Neoplasias malignas . Vol II. Pag 1562, 1998.

6-    Miller DM, Blume S, Borst M: Oncogenes, Malignat transformation an modern medicine. Am. J. Med.sci.300:59-69,1990.

7-    Guo Hb, Shen ZH, Huang CX, Ma J, Huang y Chen HL. Modulation of the basal activity of phosphatyllinositol 3 Kinase/protein KinasaB singnaling pathway in human hepatocarcinoma cells: GlycoconjJ.2000, May;17(5):315-22.

8-    Jones E Morris A: Lo esencial en célula y genética . Ed Harcourt Brace Sa, Madrid,19 99.

9-    Bechestein wo, Blunhardt G, Lobeck H, Heck H, Lemmens HP: Selection of small hepatocellular carcinoma improves long term reslts of hepatic transplantation for malignancy. Transplant In. 1994; 7 Suppll:s 238-40

10-Guo WJ, Yu Ex: Evaluation of combined therapy with cheoembolization an irradiation for hepatocellular carcinoma. Br J. Radiol 2000, oct, 73(874):1097-7

11-Steiner P. E:Cancer: race and Geography . Ed Williams an Williams an Wilkins Company, Baltimore, 1954.

12-Shea Ka, Fleming Le, Wilkson ID, Wahler Terres B, Mc Kinnon LA: Hepatocellular carcinoma incidence in Florida: Ethnic and racial distribution , Cancer 2001, Mar : 91(5): 1046-51.

13-Mucci LA; Kuper HE, Tamimi R, Lagion P, Sparios E, Trichopoul. Age at menarche and age at menopause in relation to hepatocellular carcinoma in women. BJOG, 2001.Mar;108(3):291-4.